MDTHealthcaremedtronic.com
| Metric | Oct 2024 | Jan 2025 | Apr 2025* | Jul 2025 | Oct 2025 | Jan 2026 | Apr 2026* | Jul 2026 | YoY |
|---|---|---|---|---|---|---|---|---|---|
| Operations | |||||||||
| Revenue | $8.40B | $8.29B | $8.93B | $8.58B | $8.96B | $9.02B | $9.81B | $9.76B | ▲ +13.7% |
| Gross profit | $5.46B | $5.51B | $5.78B | $5.58B | $5.90B | $5.76B | $6.41B | $6.34B | ▲ +13.7% |
| Operating income | $1.59B | $1.65B | $1.44B | $1.45B | $1.69B | $1.46B | $1.87B | $1.76B | ▲ +22.1% |
| Net income | $1.27B | $1.29B | $1.06B | $1.04B | $1.37B | $1.14B | $1.24B | $1.47B | ▲ +41.3% |
| R&Dnever filed | — | — | — | — | — | — | — | — | — |
| EPS (diluted) | 0.99 $ | 1.01 $ | — | 0.81 $ | 1.07 $ | 0.89 $ | — | 1.14 $ | ▲ +40.7% |
| Margins (% of revenue) | |||||||||
| Gross | 64.9 % | 66.5 % | 64.8 % | 65.0 % | 65.8 % | 63.8 % | 65.4 % | 65.0 % | ▼ -0.0 pt |
| Operating | 19.0 % | 19.9 % | 16.1 % | 16.8 % | 18.8 % | 16.2 % | 19.1 % | 18.1 % | ▲ +1.2 pt |
| Net | 15.1 % | 15.6 % | 11.8 % | 12.1 % | 15.3 % | 12.7 % | 12.7 % | 15.1 % | ▲ +2.9 pt |
| Balance sheet | |||||||||
| Assets | $90.04B | $89.97B | $91.68B | $90.97B | $91.35B | $91.48B | $93.03B | $93.31B | ▲ +2.6% |
| Liabilities | $41.33B | $40.36B | $43.42B | $42.84B | $42.49B | $42.29B | $42.96B | $42.46B | ▼ -0.9% |
| Equity | $48.72B | $49.62B | $48.26B | $48.13B | $48.86B | $49.20B | $50.07B | $50.85B | ▲ +5.6% |
| Cash | $1.39B | $1.24B | $2.22B | $1.27B | $1.28B | $1.15B | $1.95B | $1.69B | ▲ +32.8% |
| Capital | |||||||||
| Shares outstanding | 1.28B | 1.28B | 1.28B | 1.28B | 1.28B | 1.28B | 1.28B | 1.28B | ▼ -0.3% |
| Public floatexcluding insiders | — | — | — | — | — | — | — | — | — |
* No 10-Q is filed for a fourth quarter: these amounts are the fiscal year minus the first three quarters, all filed. EPS stays blank — dilution doesn't subtract.